Balyasny Asset Management
IMGN

Balyasny Asset Management’s Immunogen Inc IMGN Stock Holding History

Balyasny Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,827,900
Closed -$54.2M – 3256
2023
Q4 		$54.2M Buy
+1,827,900
New +$36.4M 0.1% 260

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Balyasny Asset Management's IMGN Position: Q1 2024 in Review

Balyasny Asset Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,496,758 shares — an estimated $44.4M sold.

Balyasny Asset Management first reported a position in IMGN in Q2 2016 and held it in 12 quarters. The position peaked at $44.4M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Balyasny Asset Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 1,496,758 Immunogen Inc shares in Q1 2024, an estimated $44.4M.
  • Balyasny Asset Management first reported a position in Immunogen Inc in Q2 2016 and held it in 12 quarters.
  • Balyasny Asset Management's Immunogen Inc position peaked at $44.4M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Balyasny Asset Management's 13F filing for Q1 2024, filed 13 May 2024.